Compare DSGN & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSGN | SCHL |
|---|---|---|
| Founded | 2017 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 853.8M | 790.4M |
| IPO Year | 2021 | 1995 |
| Metric | DSGN | SCHL |
|---|---|---|
| Price | $11.94 | $40.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $15.25 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 697.6K | 309.8K |
| Earning Date | 04-28-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | N/A | ★ 3442.86 |
| EPS | N/A | ★ 2.34 |
| Revenue | N/A | ★ $1,487,100,000.00 |
| Revenue This Year | N/A | $1.88 |
| Revenue Next Year | N/A | $4.05 |
| P/E Ratio | ★ N/A | $17.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.76 | $22.69 |
| 52 Week High | $17.25 | $48.07 |
| Indicator | DSGN | SCHL |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 29.80 |
| Support Level | $11.94 | $37.84 |
| Resistance Level | $13.54 | $43.97 |
| Average True Range (ATR) | 0.86 | 1.59 |
| MACD | -0.24 | -0.86 |
| Stochastic Oscillator | 15.49 | 8.33 |
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.